Medical News

RSS

Red pepper consumption can help manage appetite

Spicing up your daily diet with some red pepper can curb appetite, especially for those who don't normally eat the popular spice, according to research from Purdue University.

26 Apr 2011

UC Davis professor receives $4.8 million federal grant for child obesity study

UC Davis professor Adela de la Torre, a national expert on Chicano and Latino health issues, today received a five-year, $4.8 million federal grant to discover the best ways to help Mexican-heritage children in California maintain healthy weights.

26 Apr 2011

Signaling pathway reveals mechanism for B cell differentiation in immune response

An article in Science Signaling by researchers at the RIKEN Research Center for Allergy and Immunology (RCAI) has clarified for the first time the mechanism governing differentiation of B cells into antibody-producing plasma cells. The finding establishes a role for the extracellular signal-regulated kinase (ERK) signaling pathway in B cell differentiation, a key step toward the development of B cell-targeted drugs for treatment of autoimmune diseases and allergies.

25 Apr 2011

Kadmon Pharmaceuticals and Nano Terra announce worldwide licensing agreement

Kadmon Pharmaceuticals LLC, and Nano Terra, Inc., today announced that they have entered into an agreement under which Kadmon has been granted a perpetual, worldwide exclusive license to three novel, clinical-stage product candidates owned by Nano Terra as well as rights to Nano Terra’s drug discovery platform, Pharmacomer™ Technology. The product candidates and technology platform will be transferred to a newly formed joint venture, NT Life Sciences (“NT Life”), co-owned by Kadmon and Nano Terra, which will act as the licensor and recipient of any licensing or royalty fees subject to the agreement. Terms of the agreement were not disclosed.

25 Apr 2011

NovaSterilis novel vaccine patent

NovaSterilis Inc., a leader in the development and commercialization of supercritical carbon dioxide technology, has been granted US Patent 7,919,096. The patent, dated April 5th 2011, is entitled “Inactivating Organisms Using Carbon Dioxide At or Near Supercritical Pressure and Temperature Conditions.”

25 Apr 2011

Swearing helps control pain: Study

Researchers have found that swearing when one is in pain can act as a powerful painkiller – at least, for those who don’t normally use expletives. For these people swearing in the face of genuine pain is up to four times more effective than it is for more regular swearers they said.

25 Apr 2011

Corticosteroid creams do not cause skin thinning: Study

According to a new study, long term use of steroid creams to treat children with the skin condition known as eczema doesn't cause any major negative side effects.

25 Apr 2011

Study questions suitability of anti-retroviral drugs for the young

According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.

25 Apr 2011

Aussies avoiding regular dental check-ups: Report

According to a new report, the annual visit to the dentist is becoming a luxury for many Australians and almost 40 per cent of the population does not go for regular check-ups.

25 Apr 2011

Abbott’s mental health plan draws support and surprise

The mental health proposals by Tony Abbott may have been deemed fiscally irresponsible by the federal government but they have won backing from experts of the Australian Medical Association.

25 Apr 2011

Taro's Brampton facility regains FDA acceptable regulatory status

Taro Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has informed the Company that after a February 2011 re-inspection of its Canadian manufacturing facility, the site has an acceptable regulatory status. Therefore, the issues noted in the February 5, 2009 warning letter are considered to be resolved.

25 Apr 2011

American Academy of Pediatrics sounds alarm on chemicals

Pediatricians group warns that federal regulations have failed to protect children from dangerous exposure.

25 Apr 2011

Highmark to open additional Direct retail health insurance stores in Pennsylvania

Highmark today announced that it will open two additional Highmark Direct retail health insurance stores in Pennsylvania. The stores will be located in Lancaster and Easton and will bring the total number of stores in the state to eight.

25 Apr 2011

A.P. Pharma targets resubmission of APF530 NDA in 2012

A.P. Pharma, Inc., a specialty pharmaceutical company, today provided an update on its lead product candidate, APF530, for the prevention of chemotherapy-induced nausea and vomiting (CINV).

25 Apr 2011

Some Iowa health care institutions have little oversight

The Des Moines Register looked at state regulation of health care institutions.

25 Apr 2011

Boston Scientific launches ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System

Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval and launch of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System, the Company's third-generation drug-eluting stent technology.

25 Apr 2011

AstraZeneca selects Biologics as U.S. channel partner for vandetanib

Biologics, Inc., an integrated oncology management company, is pleased to announce it has been selected by AstraZeneca as the exclusive U.S. strategic channel partner for vandetanib.

25 Apr 2011

Supreme Court declines to expedite Virginia suit against health law

Virginia's challenge of the health law will need to take the normal route through federal appeals courts.

25 Apr 2011

Curemark CM-182 demonstrates positive results for schizophrenia in transgenic chakragati model of psychosis

Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that its compound CM-182 demonstrated positive results for schizophrenia in the transgenic chakragati (ckr) model of psychosis. The mouse model screening was performed by the Contract Research Organization, Cerca Insights.

25 Apr 2011

MACHC offers Phytel's Proactive Patient Outreach solution to members

Phytel, the leader in physician-led health improvement, and the Mid-Atlantic Association of Community Health Centers (MACHC) have formed a strategic partnership under which MACHC will support utilization of Phytel's population health management tools by its member community health centers in Maryland and Delaware.

25 Apr 2011